n(1)-methyl-2-lysergic acid diethylamide has been researched along with sulfamethoxazole in 1 studies
*Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208) [MeSH]
*Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208) [MeSH]
Studies (n(1)-methyl-2-lysergic acid diethylamide) | Trials (n(1)-methyl-2-lysergic acid diethylamide) | Recent Studies (post-2010) (n(1)-methyl-2-lysergic acid diethylamide) | Studies (sulfamethoxazole) | Trials (sulfamethoxazole) | Recent Studies (post-2010) (sulfamethoxazole) |
---|---|---|---|---|---|
16 | 0 | 13 | 5,813 | 680 | 1,216 |
Protein | Taxonomy | n(1)-methyl-2-lysergic acid diethylamide (IC50) | sulfamethoxazole (IC50) |
---|---|---|---|
Dihydropteroate synthase | Escherichia coli K-12 | 4.7 | |
5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 4.7 | |
Dihydrofolate reductase | Pneumocystis carinii | 0.1 | |
Endothelin-1 receptor | Rattus norvegicus (Norway rat) | 4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bai, C; Li, Y; Luque, R; Ou, Y; Peng, G; Yao, L | 1 |
1 other study(ies) available for n(1)-methyl-2-lysergic acid diethylamide and sulfamethoxazole
Article | Year |
---|---|
Magnetically separable Fe-MIL-88B_NH
Topics: Iron; Lysergic Acid Diethylamide; Magnetic Fields; Metal-Organic Frameworks; Nanocomposites; Particle Size; Solutions; Sulfamethoxazole; Surface Properties; Water; Water Pollutants, Chemical | 2020 |